Toll-like receptor 14 (TLR14 ) and use thereof

Details for Australian Patent Application No. 2006238475 (hide)

Owner Opsona Therapeutics Limited

Inventors Dunne, Aisling; O'Neill, Luke Anthony John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006238475

PCT Pub. Number WO2006/111946

Priority 60/672,051 18.04.05 US

Filing date 18 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 27 September 2012

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 38/00 Medicinal preparations containing peptides

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/111946 Priority application(s): WO2006/111946

10 November 2011 Assignment before Grant

  The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin The application has been assigned to Opsona Therapeutics Limited

27 September 2012 Application Accepted

  Published as AU-B-2006238475

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006238499-Adjuvant for reducing chromium (VI) ions into chromium (III)

2006238452-Fairing assembly for a motorcycle